Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue KC ACA drug formulary Coverage & PA Policy Up…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBlue KCPolicy N/A

    2025 Missouri ACA Prescription Drug List (HIX) — Small Group & Individual

    Customize your policy alerts

    Sign up for all Blue KC policy alerts

    Know when Blue KC releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Provides the 2025 prescription drug formulary and related coverage rules for Blue KC Missouri ACA individual (non-standard) and small group (2-50) members, including tiering, prior authorization, step therapy, quantity limits, preventive drug indicators, and syringe/needle coverage.

    Policy Summary
    PayerBlue KC
    Policy2025 Missouri ACA Prescription Drug List (HIX) — Small Group & Individual
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit tier exception requests for contraceptives or HIV PrEP online at bluekc.com if a preventive medication is needed that is not on the list.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2025plan year covered
    HIX BCBSKC MOformulary identifier / region
    PA/ST/QL/PVutilization controls noted
    Rx-onlysyringe/needle rule
    10/14/2025document last updated

    Formulary Coverage Criteria and Item Controls

    Syringe and needle coverage rules

    Covered when the following conditions are met:

    ALL of the following

    • Syringes and needles are covered by prescription only.
    • Coverage is limited to members taking medications requiring injection.
    • Techlite/Arkray supplies are covered at $0 cost; all other syringe/needle products are covered at a nonpreferred brand copay.
    Refer to the formulary/device listing for specific device sizes and product designations (e.g., insulin pen needles, insulin syringes).

    Tier exception and preventive drug coverage notes

    Policy Summary
    PayerBlue KC
    Policy2025 Missouri ACA Prescription Drug List (HIX) — Small Group & Individual
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit tier exception requests for contraceptives or HIV PrEP online at bluekc.com if a preventive medication is needed that is not on the list.
    SourceLink
    On This Page
    Formulary Coverage Criteria and Item ControlsFormulary Codes, Quantity Limits, and ExamplesQuantity Limit Examples and Common ValuesAuthorization, Step Therapy, and Provider Verification RequirementsFormulary Abbreviations and Key Terms

    Notes on preventive drug coverage and tier-exception process:

    ALL of the following

    • Members may request a tier exception to waive cost sharing for contraceptives or HIV PrEP medications not on the Preventive Service list; the member's physician must complete and submit the request online at bluekc.com.
    • Tier exception requests are processed via online submission by the prescribing physician.

    ALL of the following

    • Preventive tobacco-cessation coverage: the plan provides two tobacco cessation attempts per year (including prescription and OTC medications) for a 90-day regimen when prescribed by an in-network provider.
    • Preventive tobacco cessation medications may be covered at no cost under Routine Preventive Care; check member benefits for applicability.
    PV or PV* designations in the formulary indicate preventive or plan-specific preventive coverage (PV* may be $0 if copay waiver applies).

    Formulary coverage criteria by drug group

    Formulary entries specify a Drug Category and Limits/Required actions which govern coverage and utilization management.

    Each formulary entry includes a Drug Category (numeric or LCG) and a Limits/Required field indicating utilization controls such as PV, QL, ST, or PA.

    ALL of the following

    • Nicotine cessation products: commonly Drug Category = 1; Limits/Required = PV; QL (180 EA per 365 days) or QL (180 ML per 365 days).
    • Examples include bupropion hcl ER and multiple nicotine replacement products marked PV; QL (180 EA per 365 days).

    ALL of the following

    • Anticonvulsants and related agents: entries show varying Drug Category assignments and may list PA, ST, or QL (example: QL (2 EA per 1 fill)).
    • BRIVIACT limits include ST; EPIDIOLEX listed with PA in the anticonvulsant section.

    ALL of the following

    • Drug Category codes used across the formulary include numeric categories 1–5 and LCG; Limits/Required indicates the applicable control(s) for each product.

    Per-drug coverage controls appearing in this excerpt

    Selected per-drug controls noted in the table-of-contents excerpt:

    ondansetron hcl oral solution — Category = 1; Limits/Required = QL (4 ML per 1 day).
    aprepitant oral capsule 125 mg — Category = 3; Limits/Required = QL (2 EA per 30 days).
    dronabinol — Category = 3; Limits/Required = PA; QL (2 EA per 1 day).

    Formulary entries and limits

    This fragment represents a table-of-contents-style listing where drug name, category, and Limits/Required are shown.

    Entries are organized by therapeutic class with each product line showing: drug name; Drug Category; Limits/Required (may be blank or include PV, QL, ST, PA).
    Examples in this excerpt include antiparasitics (e.g., albendazole — Limits/Required = PA) and antivirals with QL values (e.g., LAGEVRIO QL (8 EA per 1 day)).

    Per-product table entries specify drug category and any limits/requirements

    Per-product table entries specify drug category and any limits/requirements (examples):

    alprazolam oral tablet 0.25/0.5/1 mg — Category = 1; Limits = QL (4 EA per 1 day).
    alprazolam ER 0.5 mg XR — Category = 2; Limits = QL (1 EA per 1 day).
    chlordiazepoxide hcl oral capsule 10 mg — Category = 1; Limits = QL (30 EA per 1 day).
    DEXCOM G6 SENSOR — Category = 2; Limits = PA.
    liraglutide — Category = 2; Limits = PA; QL (0.3 ML per 1 day).
    MOUNJARO — Category = 2; Limits = PA; QL (0.08 ML per 1 day).
    OZEMPIC — Category = 2; Limits = PA; QL (0.11 ML per 1 day).
    XARELTO ORAL SUSPENSION RECONSTITUTED — Category = 2; Limits = QL (20 ML per 1 day).

    Coverage-related flags shown in the table for specific drugs

    Coverage-related flags and quantity limits for selected drugs (examples):

    ENTRESTO ORAL CAPSULE SPRINKLE — Limits/Required = QL (8 EA per 1 day); ENTRESTO ORAL TABLET — QL (2 EA per 1 day).
    REPATHA / REPATHA SURECLICK — Limits/Required = ST; QL (0.11 ML per 1 day).
    TRYNGOLZA — Limits/Required = PA; QL (0.03 ML per 1 day).
    METYROSINE — Limits/Required = PA; QL (16 EA per 1 day).
    Selected multiple sclerosis agents — Limits/Required frequently include PA and QL with per-day or per-365-day specifications (examples in the MS section).

    Sample product control entries

    Examples of product control entries from the biologics/toxicology sections:

    DUPIXENT (various prefilled syringe/auto-injector presentations) — Limits/Required = PA; QL values provided (e.g., 0.17–0.29 ML per 1 day depending on presentation).
    TALTZ (various presentations) — Limits/Required = PA; QL values specified by presentation (examples shown in listing).
    SKYRIZI (cartridge/prefilled presentations) — Limits/Required = PA; QL (examples: 0.03–0.05 ML per 1 day for different strengths).
    LINZESS — Limits/Required = ST; QL (1 EA per 1 day).
    Several laxative and bowel prep products show PV and per-period QL values (e.g., gavilyte-c PV; QL (8000 ML per 365 days)).

    Inline coverage flags and their meaning

    Inline coverage flags used throughout the table-of-contents and their meanings:

    PA — Prior authorization required for the listed drug (examples: CERDELGA, CHOLBAM, EVRYSDI, GALAFOLD).
    QL — Quantity limits applied with explicit units/time windows (examples shown: 1 EA per 1 day; 8000 ML per 365 days; 2 fill per 365 days).
    ST — Step therapy required for specific agents (example: LINZESS marked ST).
    PV — Provider/pharmacy verification or preventive designation used for certain products (multiple oral contraceptives and vaccines marked PV).

    Examples of control markers from the table-of-contents

    Formulary control markers appearing in the TOC (partial examples):

    PA — indicates prior authorization is required for listed specialty/injectable drugs (examples: LUPRON DEPOT-PED; octreotide acetate; SIGNIFOR; SOMAVERT).
    PV — pharmacy/provider verification or preventive designation appears for many contraceptives and select vaccines/devices.
    QL — quantity limits shown with units per day or per period (examples: SIGNIFOR QL (2 ML per 1 day); ADALIMUMAB QL (0.15 EA per 1 day)).

    Formulary entries and utilization controls

    Formulary entries include drug name, drug category, and Limits/Required (may list PA, QL with specific limits, PV, or be blank).

    Listings for injectable biologics, vaccines, and specialty therapies commonly display PA and QL controls; some vaccines/devices show PV designations.

    ANY of the following

    • Examples: ORENCIA prefilled syringes — PA; QL (0.15 ML per 1 day).
    • BEYFORTUS intramuscular solution — PV; QL (2 ML per 300 days) or PV; QL (0.5 ML per 300 days).
    • STELARA and similar immunomodulators — PA; QL with small ML-per-day measures specified.

    listed_item_controls

    Usage constraints and required actions are indicated alongside items in the table of contents:

    ALL of the following

    • Quantity limits examples: METHERGINE — QL (28 EA per 1 fill); CYSTADROPS — QL (0.72 ML per 1 day); BIMATOPROST — QL (0.1 ML per 1 day).
    • Prior authorization examples: cyclosporine — PA; XIAFLEX — PA; ZOKINVY — PA; QL (4 EA per 1 day).

    Partial coverage indicators and limits

    Selected examples of limits and requirements from the drug table (partial):

    cyproheptadine hcl oral — QL (0.8 GM per 1 day).
    diphenhydramine hcl injection — QL (0.71 GM per 1 day).
    olopatadine hcl nasal — QL (1.02 GM per 1 day).
    ARNUTY ELLIPTA / BREO / ADVAIR and other inhaled products — various QL values (examples: ARNUITY ELLIPTA QL (1 EA per 1 day); BREO ELLIPTA QL (2 EA per 1 day)).
    Cystic fibrosis / pulmonary hypertension agents — several listed with PA and/or QL (examples: KALYDECO PA; ORKAMBI PA; ADEMPAS PA; QL specifications provided).

    Index-only - no coverage rules

    Index entries — informational only; no coverage rules specified in these chunks.

    This portion contains alphabetical index listings (drug names and page references). No Limits/Required coverage controls are defined in the index entries themselves; consult the main formulary sections for coverage rules and utilization controls.

    Alphabetical/index listing of drugs referenced elsewhere; informational only

    Alphabetical/index listing of drugs referenced elsewhere; informational only.

    The index lists numerous drug and product names with page/entry markers. These lines are for cross-reference and do not by themselves state coverage criteria; see the formulary sections referenced for specific limits and requirements.

    Member rights and available services for language and disability assistance

    Accessibility and non-discrimination information for members:

    Blue KC provides free language and communication assistance services to people with disabilities and to members whose primary language is not English, including qualified interpreters and written materials in other formats.
    If members need these services or have questions, contact Customer Service at 844-395-7126 (Toll free) or languagehelp@bluekc.com.

    Formulary Codes, Quantity Limits, and Examples

    Formulary control codes / legendmixed
    PAPrior Authorization
    STStep Therapy
    QLQuantity Limit
    PVPreventive (may be $0)
    Example quantity limits (covered examples)mixedCovered
    QL (2 EA per 1 day)Quantity limit example for bupropion hcl er (sr)
    QL (3 EA per 1 day)Quantity limit example for certain drugs listed in document
    Document-specific requirement codesmixed
    QLQuantity Limit — example formats: '1 EA per 1 day', '4 EA per 30 days', '84 day supply per 180 days'.
    PAPrior Authorization required
    STStep Therapy required
    LCGLocal Coverage Group or similar internal code
    Formulary limit/requirement codesmixed
    QLQuantity Limit (examples: 'QL (1 EA per 1 day)', 'QL (3 EA per 1 day)')
    PAPrior Authorization required (PA) noted for specific products
    STStep Therapy required (ST) for specific products
    Formulary requirement codesmixed
    QLQuantity Limit (examples shown: e.g., 'QL (1 EA per 1 day)', 'QL (10 EA per 1 day)', 'QL (0.3 ML per 1 day)')
    PAPrior Authorization required
    STStep Therapy
    LCGLimited Coverage Group / formulary designation (context-specific)
    Drug listing (no formal procedure or diagnosis codes)mixed
    No CPT/HCPCS/ICD codes present in this excerpt; entries are drug names, categories, and limits.
    Utilization control flagsmixed
    PAPrior Authorization required
    QLQuantity Limit (per day or per period), examples provided in parentheses
    STStep Therapy
    LCGLimited Coverage Guidance
    PVPotentially a plan/vendor-specific designation (PV) used in limits
    Formulary requirement codes shownmixed
    PAPrior Authorization required
    QLQuantity Limit (with specification)
    STStep Therapy
    PVProvider Verification / Pharmacy Verification
    LCGLimited Coverage Group / category code shown in list
    Internal drug category codesmixed
    1-5, LCG, named categoriesInternal drug category identifiers used in the formulary listing (e.g., 1, 2, 3, 4, 5, LCG, named categories like Hormonal Agents).
    quantity limit examples (placeholder)mixed
    No codes listed
    drug_category_labelsmixed
    Drug Category = 1|2|3|4|5|LCGCategory assignments appear throughout (examples: Drug Category = 3, 2, 1, 4, 5, LCG).
    Drug index (partial)mixed
    Alphabetical drug index entries (partial) — demonstrates which drugs are included in this portion of the formulary/index.
    Drug list (no codes shown)mixed
    No codes listed
    Drug/Product namesmixed
    Multiple product names and kit references listed (no standardized codes present in this excerpt).

    Quantity Limit Examples and Common Values

    Various quantity-limit (QL) examples
    Example QL: per-day unitsQL (2.5 EA per 1 day) shown for JOURNAVX
    Example QL: patch/large unitsQL (0.5 EA per 1 day) shown for fentanyl transdermal patches
    Example QL: high per-day capsQL (13 EA per 1 day) and QL (10 EA per 1 day) appear in opioid entries
    Most actionable: Common recurring QL formatsQL entries commonly specify units and a time window (examples include 'EA per 1 day', 'ML per 1 day', 'EA per 365 days')
    Nicotine product annual limit
    Nicotine patches/gum/lozengesMany cessation products marked PV with QL (180 EA per 365 days)
    Nicotine nasal sprayNICOTROL NS: ST; PV; QL (180 ML per 365 days)
    Vareniclinevarenicline tartrate (starter/continue): PV; QL (180 EA per 365 days)
    Example maximum quantity per time period
    Per-day examplesQL (0.07 EA per 1 day) for ANZEMET; QL (4 EA per 30 days) for aprepitant 125 mg
    Per-fill exampleQL (2.5 ML per 1 fill) appears in some entries
    Supply-over-period exampleQL (84 day supply per 180 days) for terbinafine oral
    Quantity limit examples (EA, ML)
    Small EA/day examplesQL (1 EA per 1 day), QL (2 EA per 1 day), QL (3 EA per 1 day) for various psychiatric agents
    ML/day exampleQL (360 ML per 365 days) and QL (60 ML per 1 day) appear for liquid formulations
    Titration/pack examplesQL (16 EA per 365 days); QL (24 EA per 365 days) for titration packs
    Examples of quantity limits (per-product)
    EA per day examplesQL (1 EA per 1 day); QL (5 EA per 1 day) for benzodiazepines and contraceptives
    ML per day examples for injectables/GLP-1MOUNJARO: PA; QL (0.08 ML per 1 day); OZEMPIC: PA; QL (0.11 ML per 1 day)
    Per-365-day fill capsExamples include QL (8000 ML per 365 days) in laxative/electrolyte products
    Quantity limits examples (various per-day or per-365-day)
    High per-day EA capsQL (16 EA per 1 day) for metyrosine
    Per-day small-volume ML examplesQL (0.02 ML per 1 day) appears for select biologic injectables
    Per-365-day EA exampleQL (55 EA per 365 days) for certain therapy packs
    Multiple QL entries with per-day or per-365-day values
    Per-day ML examples for biologicsDUPIXENT: PA; QL (0.17 ML per 1 day) and SKYRIZI cartridges: PA; QL (0.03–0.05 ML per 1 day)
    Per-day EA examples for antibodiesADALIMUMAB formulations: PA; QL (0.08–0.15 EA per 1 day)
    Large-volume per-365-day examplesGAVILYTE / PEG solutions: PV; QL (8000 ML per 365 days)
    Common QL examples
    Simple per-day EAExamples: 1 EA per 1 day for many oral tablets
    Large ML per yearExamples: 8000 ML per 365 days for some electrolyte/laxative products
    Fill-frequency capExamples: 2 fills per 365 days for some laxative powders
    Quantity limits examples for injectable products
    Injectable ML/day examplesQL (0.6 ML per 1 day) and QL (0.03–0.06 ML per 1 day) for multiple injectable biologics
    EA/day for injectable pens/syringesADALIMUMAB kits: PA; QL (0.15 EA per 1 day) or (0.08 EA per 1 day)
    Most actionable: watch unit typesInjectable QLs commonly use ML or fractional EA per day — verify unit (ML vs EA) when assessing prior authorizations
    Example quantity limits (mixed units and periods)
    Small ML/day examplesSTELARA: PA; QL (0.009 ML per 1 day) — very small ML/day values for high-potency biologics
    Per-fill EA exampleMETHERGINE: QL (28 EA per 1 fill)
    Mid-range ML/year examplebromfenac ophthalmic: QL (6.8 ML per 365 days)
    Mixed-unit QL examples
    Per-fill tablet limitsQL (28 EA per 1 fill) for selected obstetric agents (e.g., METHERGINE)
    Per-day ML small-volumeQL (0.72 ML per 1 day) for select ophthalmic/ocular solutions
    Per-year ML totalsQL (6.8 ML per 365 days) for certain ophthalmic anti-inflammatories
    Quantity limits shown (GM/EA/ML per day examples)
    GM per day examplescyproheptadine: QL (0.8 GM per 1 day); diphenhydramine injection: QL (0.71 GM per 1 day)
    EA per day examplesARNUITY ELLIPTA: QL (1 EA per 1 day); BREO ELLIPTA: QL (2 EA per 1 day)
    Most actionable: unit diversityQL values use GM, EA, ML depending on formulation — confirm unit when applying limits

    Authorization, Step Therapy, and Provider Verification Requirements

    Prior Authorization

    Prior Authorization required

    PA = Prior Authorization. The Plan requires you or your physician to get prior authorization for certain drugs; without approval the plan may not cover the drug.

    Step Therapy

    Tier exception requests for contraceptives & PrEP

    To request a tier exception to waive cost sharing for contraceptives or HIV PrEP not on the Preventive Service list, the member's physician must complete and submit the online tier‑exception request at bluekc.com.

    • Applies to contraceptives and HIV PrEP preventive medications
    • Physician must submit request online at bluekc.com
    Note

    Formulary limits / requirement flags

    Formulary entries use Limits/Required flags — PV (prior verification), QL (quantity limit), ST (step therapy), and PA (prior authorization) — to indicate utilization controls that may apply to a drug.

    • PV indicates plan/pharmacy verification or preventive designation
    • QL denotes numeric quantity limits (e.g., per day or per 365 days)
    • ST denotes step therapy requirements
    • PA denotes prior authorization is required
    Prior Authorization

    PA indicated on formulary drug list

    Multiple products in the drug list are marked with 'PA', indicating prior authorization is required for coverage (examples include dronabinol and many high‑cost specialty agents listed throughout the TOC).

    • Dronabinol — Limits/Required = PA (see therapy adjuncts)
    • Specialty/genetic drugs (e.g., CERDELGA, CHOLBAM) — Limits/Required = PA
    • Cystic fibrosis agents (e.g., KALYDECO, ORKAMBI) — Limits/Required = PA
    Billing Rule

    Quantity limits (QL) defined on entries

    Quantity limits (QL) are specified for many products and are shown as numeric constraints (examples in the formulary include per‑day or per‑period values such as QL (2 EA per 1 day), QL (4 EA per 30 days), and annual limits like QL (180 EA per 365 days)).

    • Examples: QL (2 EA per 1 day); QL (4 EA per 30 days); QL (180 EA per 365 days)
    • Some supplies show fill‑frequency constraints (e.g., QL 2 fill per 365 days)
    Prior Authorization

    Follow Limits/Required indicators in formulary table

    Formulary table entries include utilization controls such as PA (prior authorization), ST (step therapy), and PV (pharmacy/provider verification) next to product names — providers must follow these indicated authorization actions for affected agents.

    • PV may denote vaccine/program or preventive designation requiring verification
    • ST indicates a required trial of preferred agents before coverage of non‑preferred agents
    • PA indicates prior authorization must be obtained before fill
    Prior Authorization

    PA required for CGM devices and sensors

    Continuous glucose monitoring devices and related transmitters/sensors (examples: DEXCOM G6/G7 devices and GUARDIAN sensors/transmitters) are flagged 'PA' in the formulary; obtain prior authorization before ordering/dispensing these devices.

    • DEXCOM G6 Receiver/Sensor/Transmitter — Limits/Required = PA
    • DEXCOM G7 devices and sensors — Limits/Required = PA
    • GUARDIAN 4 Sensor/Transmitter — Limits/Required = PA
    Prior Authorization

    PA required for blood/hematology and biologic agents

    High‑cost biologics and hematology/blood formation agents are designated with 'PA' in the formulary; providers must secure prior authorization for these agents before administration or dispense.

    • Examples: ARANESP, NEULASTA, PROMACTA, NEULASTA ONPRO — Limits/Required = PA
    • Many immunomodulators and specialty injectables (e.g., ORENCIA, ACTEMRA) have PA and QL flags
    Note

    Authorization and QL indicators present in TOC

    The Table of Contents shows PA, ST and QL indicators alongside many drug entries (for example, ENTRESTO entries show QL; REPATHA shows ST and QL; multiple MS agents are marked PA). Review the TOC flags to determine required prior authorization, step therapy, or quantity limits for a given product.

    • ENTRESTO — QL examples shown
    • REPATHA / REPATHA SURECLICK — ST; QL (0.11 ML per 1 day)
    • Several MS agents — PA and QL noted
    Prior Authorization

    PA plus quantity limits on select biologics

    Some products listed in the TOC explicitly combine prior authorization and quantity limits (e.g., DUPIXENT and TALTZ show PA and QL); secure authorization and adhere to the stated QL when prescribing or dispensing these agents.

    • DUPIXENT prefills — Limits/Required = PA; QL (per day values shown)
    • TALTZ prefilled syringes — Limits/Required = PA; QL (per day values shown)
    Step Therapy

    Step therapy (ST) entries — follow trial requirements

    Some agents are subject to Step Therapy (ST) or LCG designations in the formulary; follow step‑therapy requirements (trial of preferred agents) before submitting for non‑preferred product coverage.

    • Examples: pimecrolimus — Limits/Required = ST
    • LINZESS — Limits/Required = ST; QL (1 EA per 1 day)
    Prior Authorization

    PA for specialty/genetic enzyme disorder drugs

    Several specialty and genetic/enzyme disorder therapies are marked 'PA' in the list (e.g., CERDELGA, CHOLBAM, EVRYSDI); providers must request prior authorization for these therapies before treatment.

    • CERDELGA, CHOLBAM — Limits/Required = PA
    • EVRYSDI ORAL SOLUTION — Limits/Required = PA; QL (8 ML per 1 day)
    Billing Rule

    Observe QL and fill‑frequency constraints

    The formulary lists quantity limits and fill frequency constraints for many products (examples: QL (1 EA per 1 day); QL (8000 ML per 365 days); QL (2 fill per 365 days)). Ensure prescribed quantities and refill timing comply with the stated QL.

    • Many laxative and electrolyte preparations show PV plus QL (e.g., gavilyte-c QL 8000 ML per 365 days)
    • Some products restrict fills per 365‑day period (e.g., 2 fill per 365 days)
    Prior Authorization

    PA required for select specialty/injectable therapies

    Numerous specialty and injectable therapies are listed with Limits/Required = PA (examples include LUPRON DEPOT‑PED and octreotide formulations); obtain prior authorization per the formulary before administration or billing.

    • LUPRON DEPOT‑PED (3‑month and 6‑month) — Limits/Required = PA
    • Octreotide acetate injections/subcutaneous — Limits/Required = PA
    Documentation Required

    Pharmacy verification (PV) and QL for contraceptives

    Many oral contraceptives and related products show PV (pharmacy verification) and may include QL; pharmacies/providers must perform the indicated verification and adhere to quantity rules when dispensing contraceptives.

    • Numerous contraceptive products list Limits/Required = PV
    • Selected contraceptives also include QL (e.g., 1 EA per 1 day)
    Prior Authorization

    General prior authorization requirement

    Across the formulary many listed drugs include 'PA' in the Limits/Required field indicating prior authorization is required for coverage. Providers should check the TOC entry for PA flags before prescribing.

    • PA is used broadly across therapeutic classes to control access to specific drugs
    • If PA is not obtained the plan may deny coverage
    Documentation Required

    PV designation for vaccines/devices (verification)

    Some vaccines and devices are marked 'PV', indicating program or vaccine‑specific processing or pharmacy/provider verification is required prior to dispensing; follow PV processing instructions where indicated.

    • BEYFORTUS intramuscular syringes show PV with QL examples
    • PV flags appear on vaccine/device entries in the TOC
    Prior Authorization

    Prior authorization example — cyclosporine

    Example: cyclosporine appears in the formulary with Limits/Required = PA; prior authorization must be obtained for coverage of cyclosporine as indicated.

    • Cyclopsorine listed with Limits/Required = PA in the TOC
    Billing Rule

    Quantity limits noted (examples)

    Multiple items include Limits/Required = QL indicating quantity limits apply (examples: METHERGINE QL (28 EA per 1 fill); CYSTADROPS QL (0.72 ML per 1 day)). Prescribers must follow these QL values when authorizing therapy.

    • METHERGINE — QL (28 EA per 1 fill)
    • CYSTADROPS — QL (0.72 ML per 1 day)
    Prior Authorization

    Additional PA indicators — partial list

    The formulary includes many additional PA examples in limits/required fields (partial list includes KALYDECO, ORKAMBI, ADEMPAS, ambrisentan, bosentan) — confirm PA requirements for these agents before prescribing or billing.

    • KALYDECO — Limits/Required = PA
    • ORKAMBI — Limits/Required = PA; QL shown
    • ADEMPAS — Limits/Required = PA; QL (3 EA per 1 day)
    Note

    Drug index is informational (no authorization rules)

    The alphabetical drug and device index is informational only and does not contain coverage or authorization rules; use the TOC entries to identify PA, ST, PV, or QL requirements for specific products.

    • Index entries list product names and page references
    • Authorization flags are shown in the TOC, not the index
    Documentation Required

    Use drug index for reference; confirm rules in TOC

    The drug index pages list product names for reference; they do not replace the Table of Contents where Limits/Required flags (PA, QL, ST, PV) are indicated — check the TOC for authorization and quantity rules.

    • Index provides quick lookup of drug names
    • Authorization and QL flags must be confirmed in the TOC entries
    Note

    Drug Index Listing — reference only

    The continuation of the drug index reiterates that index listings are for reference only and do not show prior authorization or quantity‑limit rules — always consult the TOC entries for required authorizations and limits.

    • Index spans multiple chunks/pages; no Limits/Required data in index entries
    • TOC entries contain the operational flags to follow

    Formulary Abbreviations and Key Terms

    Definitions: PV, ST, QL, PA (summary)
    PV — Preventive drug indicatorPV indicates preventive drugs; PV* may be available at $0 if Health Care Reform copay waiver is approved (check benefits)
    ST — Step TherapyST indicates the plan may require trying specified drugs first before covering another drug for that condition
    QL — Quantity LimitQL indicates the plan limits the amount of drug covered, usually expressed as units over a time period (EA/ML/GM per X days)
    PA — Prior AuthorizationPA indicates prior authorization is required before coverage; without approval the plan may not cover the drug
    Step Therapy definition and notes
    Step Therapy (ST) definitionST — the Plan may require you to try certain drugs first to treat a condition before covering another drug for that condition
    Example usageDocument flags LINZESS and BELSOMRA as ST in the formulary entries
    Effect on prescribingProviders should verify ST requirements before prescribing alternatives to ensure coverage
    Quantity Limit (QL) definition
    Quantity Limit (QL) definitionQL — numeric restriction on supply over a defined time period (examples: '1 EA per 1 day', '8000 ML per 365 days')
    Presentation in listingQL values are shown inline with drug entries and specify unit and time window (EA, ML, GM per day or per 365 days)
    Provider action implicationPharmacists and providers must confirm QL when dispensing or submitting PA/PV requests to avoid denials
    Limits/Required codes summary
    Limits/Required code setPV = Prior Verification; QL = Quantity Limit; ST = Step Therapy; PA = Prior Authorization
    How codes appearCodes appear in the 'Limits/ Required' column beside drug entries to indicate utilization controls
    Common combined flagsEntries may combine codes (e.g., PV; QL (180 EA per 365 days); ST; PA) — interpret all flags when assessing coverage
    QL definition example (legend)
    QL example in legendQL denotes Quantity Limit; examples in document include 'QL (0.5 EA per 1 day)' for fentanyl patches
    Legend cross-referenceLegend defines QL, PA, ST and PV and explains how to interpret entries
    ApplicationUse legend definitions to map inline table flags to authorization and dispensing actions
    PA (Prior Authorization) definition and example
    PA definition (short)PA = Prior Authorization. The Plan requires you or your physician to get approval before filling certain drugs; without approval the plan may not cover the drug.
    Examples in formularyMany specialty and high-cost drugs (e.g., KALYDECO, ADALIMUMAB products) are marked PA in the listing
    Provider stepProviders must submit PA requests via plan procedures to obtain coverage authorization
    ST (Step Therapy) definition and example
    ST definition (short)ST indicates the Plan may require trying certain drugs first (step therapy) before covering alternatives
    Formulary exampleLINZESS and BELSOMRA are marked ST in the listing
    Clinical implicationConfirm ST requirements before prescribing non-preferred agents to avoid coverage issues
    Drug Category definition
    Drug Category definitionDrug Category — numeric or coded classification used in the formulary (examples: 1–5, LCG); appears beside drug names
    UsageCategory guides tiering and may indicate preferred vs non-preferred status
    ExamplesEntries throughout the table show category values (e.g., Category = 1, 2, 3, 4, 5, LCG)
    Formulary requirement codes summary
    Formulary shorthand codesCommon shorthand: PA, QL, ST, LCG, PV — used inline in drug listings to indicate requirements
    How to read combined flagsCombined flags (e.g., PA; QL (0.17 ML per 1 day)) indicate both authorization and a numeric limit apply
    Where shownCodes appear in 'Limits/ Required' column next to drug names in the Table of Contents and index
    QL expressed per time period (definition and examples)
    QL per time period noteQL values can be expressed per day, per fill, or per year (e.g., 'EA per 1 day', 'fill per 365 days', 'ML per 365 days')
    ExamplesQL (2 fill per 365 days); QL (354 ML per 365 days); QL (180 EA per 365 days)
    Operational impactPharmacies must enforce the numeric limit over the specified window when dispensing
    PA short label
    PA (short label)PA — Prior Authorization required before coverage; defined in the legend
    Document instructionThe Plan may deny coverage if PA is not obtained prior to dispensing
    Examples in listingMultiple specialty drugs are flagged PA in the formulary index
    PV (Provider/Pharmacy Verification) definition
    PV (Provider/Pharmacy Verification)PV indicates pharmacy or program-specific verification; PV* may denote preventive/copay-waiver applicability
    ExamplesMany contraceptives and nicotine cessation products display PV alongside QL
    Member actionProviders may need to submit documentation or use specific claim codes per PV requirements
    LCG (Limited Coverage Guidance) definition
    LCG — Limited/Local Coverage GuidanceLCG indicates a formulary grouping or limited coverage guidance used in the listing (appears with numeric categories)
    ApplicationLCG entries appear for select generics or category-based items in the table
    ExampleSome product lines and generics are marked LCG in Table of Contents entries
    Formulary shorthand (PA, QL, ST, LCG, PV)
    Formulary shorthand summaryPA, QL, ST, LCG, PV are used consistently across entries to indicate authorization, limits, step therapy, local coverage guidance, and verification
    Interpretation tipWhen multiple codes appear, all listed requirements must be satisfied for coverage
    Where to confirmCheck the plan portal or Blue KC provider resources for PA forms and PV procedures
    Prior Authorization (short label)
    PA label (anchor)PA indicates prior authorization; see legend for details
    Usage in tablePA shown next to many specialty agents and devices in the drug list
    Provider actionSubmit PA per Blue KC instructions to avoid claim denials
    Quantity Limit (QL) label with examples
    QL label with examplesQL denotes quantity limit — examples: 'QL (1 EA per 1 day)', 'QL (8000 ML per 365 days)', 'QL (2 fill per 365 days)'
    Where usedApplied to tablets, liquids, inhalers, injectables across the formulary
    EnforcementPharmacies must track dispensing against the specified time window
    Step Therapy designation label
    ST designation labelST — Step Therapy required; example: TRINTELLIX marked ST; LINZESS marked ST
    ImplicationPrior trial of preferred therapies may be required before coverage of ST-marked drugs
    Provider stepDocument prior therapies when requesting PA for ST agents
    Limited Coverage Guidance (label)
    LCG label (short)LCG used as a local/limited coverage designation within the formulary listing
    ContextAppears alongside numeric Drug Category values in the Table of Contents
    Practical noteLCG may affect coverage tiers and preferred status; verify with plan guidance
    PV plan-specific designation used alongside limits
    PV plan-specific designationPV marks items that require pharmacy/program verification; PV* may indicate preventive/copay-waiver applicability
    ExamplesContraceptives frequently marked PV; nicotine cessation products also show PV
    Member coverage notePV items may be covered at $0 under preventive benefit if waiver applies — check member benefits
    Quantity Limit (specified per time period or fill count)
    QL per time or fill countQuantity Limits are specified per time period or per fill (examples: 'EA per 1 day', 'fill per 365 days')
    ExamplesQL (2 EA per 1 day); QL (2 fill per 365 days); QL (112 EA per 28 days)
    Actionable reminderConfirm the exact period (per day, per fill, per 365 days) when applying the QL to a claim
    Prior Authorization (short)
    PA short labelPA — Prior Authorization required for coverage of the listed item (see legend)
    EffectWithout PA approval the plan may deny coverage; many specialty agents are flagged PA
    Provider instructionFollow Blue KC PA submission procedures to request authorization
    Provider/Pharmacy Verification (PV) definition
    Provider/Pharmacy Verification (PV)PV indicates pharmacy verification or program-specific verification is required (examples: many contraceptives marked PV)
    Where to confirmCheck plan portal or pharmacy system for PV processing rules
    Coverage implicationPV items may be processed differently for preventive benefits — verify member eligibility
    Step Therapy (short label)
    ST label (short)ST denotes Step Therapy; example: TRINTELLIX ST; LINZESS ST
    Impact on utilizationST may require evidence of trial/failure of preferred agents prior to coverage
    Provider actionInclude prior treatment history when requesting exceptions or PA for ST drugs
    PA label (anchor)
    PA label (redundant)PA — Prior Authorization required; included in legend and inline listings
    Why listedRepeated as an anchor definition to emphasize provider responsibilities for specialty drugs
    ExamplesMultiple entries across the formulary show PA flag for high-cost therapies
    PV label (pharmacy verification) example
    PV label (pharmacy verification) exampleMany contraceptives and laxative kits show PV in Limits/Required (e.g., hailey 24 fe: PV)
    Operational notePharmacies should follow PV procedures to validate coverage and preventive status
    Member implicationPV items may be eligible for $0 cost-share under preventive rules if waiver applies
    QL label (quantity limit) example
    QL label exampleQL — quantity limits such as 'QL (8000 ML per 365 days)' or 'QL (2 fill per 365 days)' appear in listings
    Where usedCommon for laxatives, inhalation solutions, and chronic therapy packs
    EnforcementPharmacies must enforce cumulative limits over the stated period
    PA / QL / PV combined examples
    Combined PA/QL/PV examplesEntries often combine requirements (e.g., 'PA; QL (0.15 EA per 1 day)'; 'PV; QL (8000 ML per 365 days)')
    Interpretation guidanceAll listed controls must be addressed for coverage (submit PA, adhere to QL, complete PV steps)
    Example entriesADALIMUMAB variants: PA; QL (0.15 EA per 1 day); laxative kits: PV; QL (8000 ML per 365 days)
    PA shorthand
    PA shorthandPA — Prior Authorization
    Usage noteUsed widely across the formulary to indicate required prior approvals
    Where to find detailsSee Blue KC provider resources for PA submission guidance
    QL shorthand
    QL shorthandQL — Quantity Limit
    Examples of shorthand entriesShown as 'QL (X EA per Y days)' or 'QL (Z ML per 365 days)' inline with drugs
    Practical tipConfirm unit (EA/ML/GM) when applying shorthand to dispensing rules
    Drug Category codes explanation
    Drug Category codes explanationCategories include numeric tiers 1–5 and LCG; used to classify drugs within the formulary
    Effect on coverageCategory often maps to tiering and cost-sharing differences; check benefit documents
    Where displayedDisplayed beside drug names throughout the Table of Contents and index
    PA indicator used in Limits/Required
    PA indicator in Limits/RequiredPA is used in the Limits/Required field to denote drugs that require prior authorization (e.g., KALYDECO: PA)
    Implication for claimsClaims for PA-marked drugs may be denied without prior approval
    Provider instructionSubmit PA requests per plan procedures prior to dispensing specialty agents
    QL description and unit examples
    QL description and unitsQL entries express limits with units such as GM per 1 day, EA per 1 day, ML per 1 day or per 365 days (examples throughout document)
    Example unitsGM, EA, ML are used depending on formulation and route of administration
    Operational noteEnsure claims systems interpret and accumulate the correct unit types when enforcing QL
    ST example (documented)
    ST example (BELSOMRA)BELSOMRA marked ST; QL (1 EA per 1 day)
    How ST appearsST shown inline in Limits/Required next to drug entries
    Provider actionDocument trials of preferred agents when requesting PA for ST drugs
    Index of Drugs definition
    Index of Drugs definitionAlphabetical index entries list drug names and reference pages; index itself does not include coverage criteria
    PurposeProvides quick reference to where drugs appear in the formulary and their page references
    NoteCheck the referenced Table of Contents entries for limits/PA/ST details
    Drug index reference
    Drug index referenceDrug index lists product names and where they appear in the document; coverage rules are specified in the main Table of Contents entries
    UsageUse index to locate the detailed entry for limits and requirements
    FormatIndex lines show drug name followed by page/entry markers
    Accessibility and Language Services (Blue KC assistance statement)
    Accessibility & Language ServicesBlue KC provides free aids and services (qualified interpreters, written translations, large print, sign language) to people with disabilities or with limited English proficiency; contact Customer Service 844-395-7126
    Multilingual noticeInformation and interpreter services are available in Spanish and Chinese per the document examples
    Contact detailsCustomer Service: 844-395-7126; email: languagehelp@bluekc.com